Donatella Marino

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma.

Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma.

Journal: Research (Washington, D.C.)

Published: November 20, 2025

The role of the molecular tumor board: learnings from the ROME trial.

The role of the molecular tumor board: learnings from the ROME trial.

Journal: NPJ precision oncology

Published: November 18, 2025

Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis.

Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis.

Journal: Liver cancer

Published: August 26, 2025

Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study.

Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study.

Journal: Liver cancer

Published: April 29, 2025

The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 04, 2025

Clinical relevance and methodological approach for the assessment of drug-drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF).

Clinical relevance and methodological approach for the assessment of drug-drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF).

Journal: ESMO open

Published: January 22, 2025

Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.

Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.

Journal: Nature medicine

Published: December 27, 2024

Title Not Found

Title Not Found

Journal: Recenti progressi in medicina

Published: November 17, 2024

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial.

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial.

Journal: ESMO open

Published: September 26, 2024

Adoption of electronic patient-reported outcomes in cancer clinical practice: the point of view of Italian patients.

Adoption of electronic patient-reported outcomes in cancer clinical practice: the point of view of Italian patients.

Journal: ESMO real world data and digital oncology

Published: February 19, 2024

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial.

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology

Published: October 05, 2023

The role of component separation in the treatment of severe diastasis recti abdominis: a new indication for a known technique.

The role of component separation in the treatment of severe diastasis recti abdominis: a new indication for a known technique.

Journal: European review for medical and pharmacological sciences

Published: September 26, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026